En Es
Categories

FUJIREBIO

FUJIREBIO

Fujirebio is a global leader in the field of IVD testing with more than 50 years’ experience in the conception, development, production and worldwide commercialization of robust IVD products. These span the range from specialized testing to fully automated routine clinical laboratory testing solutions covering a variet ...
Gold member
Products Covid-19Summary
Close

Covid-19 FUJIREBIO

Clinical Laboratory

SARS-CoV-2 Antibody Test
Lumipulse G SARS-CoV-2 Ag

The CE marked Lumipulse G SARS-CoV-2 Ag is designed for in vitro diagnostic (IVD) use with the Lumipulse G system for the detection and quantitative measurement of SARS-CoV-2 antigen in human nasopharyngeal swab or saliva. The assay is meant to be used as a diagnostic tool for the confirmation of a SARS-CoV-2 infection and utilizes proven CLEIA (chemiluminescent enzyme immunoassay) technology with results available in up to 35 minutes.
More details

BNP Control
Lumipulse® BNP Control

The CE marked Lumipulse® BNP Control are intended for use as an assayed quality control to monitor the precision of laboratory testing procedures for the analysis of human B-type natriuretic peptide (BNP) on the LUMIPULSE G Systems.
More details

AMH Immunoreaction Cartridges
Lumipulse® G AMH (anti-Müllerian hormone)

The CE marked Lumipulse® G AMH (anti-Müllerian hormone) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the fully automated quantitative measurement of AMH in specimens based a two-step immunoassay method on the LUMIPULSE G System. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

LH Immunoreaction Cartridges
Lumipulse® G LH (Luteinizing Hormone)

The CE marked Lumipulse® G LH (Luteinizing Hormone) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of luteinizing hormone (LH) in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

HIV p24 Antigen Test
INNOTEST® HIV Antigen mAb

The CE marked INNOTEST® HIV Antigen mAb is an enzyme immunoassay for the qualitative detection of HIV p24 antigen in human serum, plasma, and cell culture supernatant. The kit contains reagents for confirmation of HIV p24 antigens in repeatedly reactive samples.
More details

COVID-19 Test
iAMP COVID-19 Detection Kit

The CE marked iAMP COVID-19 Detection Kit is designed for the qualitative nucleic acid detection of SARS-CoV-2 (COVID-19) on naso- or oropharyngeal swabs without pre-treatment. Using isothermal amplification with real time fluorescence detection, the kit requires limited hands-on time and delivers fast sample-to-result within 75 to 90 minutes only.
More details

SARS-CoV-2 Assay
ESPLINE® SARS-CoV-2

The CE marked ESPLINE® SARS-CoV-2 is a cassette-style immunochromatographic assay for in vitro diagnostic (IVD) use for the detection of SARS-CoV-2 antigen directly from nasopharyngeal swab fluid. It can detect SARS-CoV-2 within 30 minutes using a simple procedure without any special instruments and is intended for use as an aid in the diagnosis of SARS-CoV-2 infection.
More details
Close

About FUJIREBIO

Fujirebio is a global leader in the field of IVD testing with more than 50 years’ experience in the conception, development, production and worldwide commercialization of robust IVD products. These span the range from specialized testing to fully automated routine clinical laboratory testing solutions covering a variety of disease states.

Recently updated

T4 Immunoreaction Cartridges
Lumipulse® G T4 (Thyroxine)

The CE marked Lumipulse® G T4 (Thyroxine) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of thyroxine (T4) in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

T3 Immunoreaction Cartridges
Lumipulse® G T3 (Triiodothyronine)

The CE marked Lumipulse® G T3 (Triiodothyronine) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of triiodothyronine (T3) in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

SCC Immunoreaction Cartridges
Lumipulse® G SCC (Squamous Cell Carcinoma)

The CE marked Lumipulse® G SCC (Squamous Cell Carcinoma) immunoreaction cartridges are intended for in vitro diagnostic use with the LUMIPULSE G instruments for the quantitative measurement of squamous cell carcinoma (SCC) antigen in human serum or plasma samples as an aid in the management of patients with squamous cell carcinoma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme ImmunoAssay) technology with results that are available in up to 35 minutes.
More details

Clinical Laboratory

T4 Immunoreaction Cartridges
Lumipulse® G T4 (Thyroxine)

The CE marked Lumipulse® G T4 (Thyroxine) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of thyroxine (T4) in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

T3 Immunoreaction Cartridges
Lumipulse® G T3 (Triiodothyronine)

The CE marked Lumipulse® G T3 (Triiodothyronine) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of triiodothyronine (T3) in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

SCC Immunoreaction Cartridges
Lumipulse® G SCC (Squamous Cell Carcinoma)

The CE marked Lumipulse® G SCC (Squamous Cell Carcinoma) immunoreaction cartridges are intended for in vitro diagnostic use with the LUMIPULSE G instruments for the quantitative measurement of squamous cell carcinoma (SCC) antigen in human serum or plasma samples as an aid in the management of patients with squamous cell carcinoma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme ImmunoAssay) technology with results that are available in up to 35 minutes.
More details

Renin Immunoreaction Cartridges
Lumipulse® G Renin

The CE marked Lumipulse® G Renin immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of active renin in human serum or plasma.
More details

pTau 181 Immunoreaction Cartridges
Lumipulse® G pTau 181

The CE marked Lumipulse® G pTau 181 immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 181 (pTau 181) in human cerebrospinal fluid (CSF). This CSF biomarker is intended to be used as an aid for diagnosis in patients with cognitive impairment who are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline. The CSF biomarker supports the probability of AD pathology only as an adjunct to other diagnostic evaluations.
More details

PSA-N Immunoreaction Cartridges
Lumipulse® G PSA-N (Prostate Specific Antigen)

The CE marked Lumipulse® G PSA-N (Prostate Specific Antigen) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of prostate specific antigen (PSA) in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

Prolactin Immunoreaction Cartridges
Lumipulse® G Prolactin

The CE marked Lumipulse® G Prolactin immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of prolactin in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

ProGRP Immunoreaction Cartridges
Lumipulse® G ProGRP (Pro-Gastrin-Releasing Peptide)

The CE marked Lumipulse® G ProGRP (Pro-Gastrin-Releasing Peptide) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of Pro-gastrin-releasing peptide [ProGRP (31-98)] in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes. The ProGRP assay is intended to be used as an aid in differential diagnosis and for monitoring of patients with Small Cell Lung Cancer.
More details

Progesterone-N Immunoreaction Cartridges
Lumipulse® G Progesterone-N

The CE marked Lumipulse® G Progesterone-N immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of Progesterone in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

PIVKA-II Immunoreaction Cartridges
Lumipulse® G PIVKA-II

The CE marked Lumipulse® G PIVKA-II immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of protein induced vitamin K absence or antagonist-II (PIVKA-II) in serum. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

Pepsinogen II Immunoreaction Cartridges
Lumipulse® G Pepsinogen II

The CE marked Lumipulse® G Pepsinogen II unique immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative determination of Pepsinogen II in human serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme ImmunoAssay) technology with results that are available in up to 35 minutes.
More details

Pepsinogen I Immunoreaction Cartridges
Lumipulse® G Pepsinogen I

The CE marked Lumipulse® G Pepsinogen I unique immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative determination of Pepsinogen I in human serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme ImmunoAssay) technology with results that are available in up to 35 minutes.
More details

Myoglobin Immunoreaction Cartridges
Lumipulse® G Myoglobin

The CE marked Lumipulse® G Myoglobin immunoreaction cartridges are intended for in vitro diagnostic use with the LUMIPULSE G instruments for the quantitative measurement of myoglobin in human serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme ImmunoAssay) technology with results that are available in up to 35 minutes.
More details

Mesothelin Immunoreaction Cartridges
Lumipulse® G Mesothelin

The CE marked Lumipulse® G Mesothelin immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative determination Soluble Mesothelin Related Peptides (SMRP) in human serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

LH Immunoreaction Cartridges
Lumipulse® G LH (Luteinizing Hormone)

The CE marked Lumipulse® G LH (Luteinizing Hormone) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of luteinizing hormone (LH) in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

KL-6 Immunoreaction Cartridges
Lumipulse® G KL-6 (Krebs von den Lungen)

The CE marked Lumipulse® G KL-6 (Krebs von den Lungen) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of sialylated carbohydrate antigen, KL-6 in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

Insulin-N Immunoreaction Cartridges
Lumipulse® G Insulin-N

The CE marked Lumipulse® G Insulin-N immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of insulin in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

IgE (Immunoglobulin E) Immunoreaction Cartridges
Lumipulse® G IgE (Immunoglobulin E)

The CE marked Lumipulse® G IgE (Immunoglobulin E) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of immunoglobulin E (IgE) in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

hs Troponin I Immunoreaction Cartridges
Lumipulse® G hs Troponin I

The CE marked Lumipulse® G hs Troponin I immunoreaction cartridges are intended for in vitro diagnostic use with the LUMIPULSE G instruments for the quantitative and high sensitive measurement of cardiac Troponin-I (cTnI) in human serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme ImmunoAssay) technology with results that are available in up to 35 minutes.
More details

HMW Adiponectin Immunoreaction Cartridges
Lumipulse® G HMW Adiponectin

The CE marked Lumipulse® G HMW Adiponectin unique mono-test immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of high-molecular-weight adiponectin (HMW Adiponectin) in serum or plasma. The assay utilizes proven CLEIA (Chemiluminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

HBsAg-Quant Immunoreaction Cartridges
Lumipulse® G HBsAg-Quant

The CE marked Lumipulse® G HBsAg-Quant immunoreaction cartridges are intended for in vitro diagnostics (IVD) use with the LUMIPULSE G System for the qualitative and quantitative detection of hepatitis B surface antigen (HBsAg) in human serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes. The product is indicated as an aid for screening and diagnosis of hepatitis B viral infection and for professional use only.
More details

HBeAg Immunoreaction Cartridges
Lumipulse® G HBeAg

The CE marked Lumipulse® G HBeAg immunoreaction cartridges are intended for in vitro diagnostics (IVD) use with the LUMIPULSE G System for the qualitative detection of hepatitis B e antigen (HBeAg) in human serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes. The product is indicated as an aid in the diagnosis and monitoring of hepatitis B viral infection and for professional use only.
More details

HBeAb-N Immunoreaction Cartridges
Lumipulse® G HBeAb-N

The CE marked Lumipulse® G HBeAb-N immunoreaction cartridges are intended for in vitro diagnostic use with the LUMIPULSE G System for the qualitative detection of antibody to hepatitis B e antigen (anti-HBe) in human serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes. The product is indicated as an aid in the diagnosis and monitoring of hepatitis B viral infection and for professional use only.
More details

HBcrAg Immunoreaction Cartridges (RUO)
Lumipulse® G HBcrAg (RUO)

The Lumipulse® G HBcrAg immunoreaction cartridges are intended for Research Use Only (not for use in diagnostic procedures) with the LUMIPULSE G System for the quantitative detection of hepatitis B virus core-related antigen in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

HBcIgM Immunoreaction Cartridges
Lumipulse® G HBcIgM

The CE marked Lumipulse® G HBcIgM immunoreaction cartridges are intended for in vitro diagnostics (IVD) use with the LUMIPULSE G System for the qualitative detection of IgM antibody to hepatitis B core antigen (anti-HBc IgM) in human serum or plasma. The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

FT4-N Immunoreaction Cartridges
Lumipulse® G FT4-N (Free Thyroxine)

The CE marked Lumipulse® G FT4-N (Free Thyroxine) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of free thyroxine (FT4) in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

FT3-III Immunoreaction Cartridges
Lumipulse® G FT3-III (Free Triiodothyronine)

The CE marked Lumipulse® G FT3-III (Free Triiodothyronine) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of free triiodothyronine (FT3) in serum or plasma. This assay uses a mouse monoclonal antibody. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

FSH-N Immunoreaction Cartridges
Lumipulse® G FSH-N (Follicle-Stimulating Hormone)

The CE marked Lumipulse® G FSH-N (Follicle-Stimulating Hormone) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of follicle-stimulating hormone (FSH) in serum or plasma. The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

Free PSA Immunoreaction Cartridges
Lumipulse® G Free PSA (Free Prostate Specific Antigen)

The CE marked Lumipulse® G Free PSA (Free Prostate Specific Antigen) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of free prostate specific antigen (free PSA) in human serum or plasma. The Lumipulse G Free PSA assay is intended to be used in conjunction with the Lumipulse G PSA-N assay to determine the % free PSA value in men aged 50 years or older whose total PSA values are between 4 and 10 ng/mL and whose DRE is not suspicious for cancer. The % free PSA value can be used as an aid in distinguishing prostate cancer from benign disease. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

Ferritin-N Immunoreaction Cartridges
Lumipulse® G Ferritin-N

The CE marked Lumipulse® G Ferritin-N immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of ferritin in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

E2-III Immunoreaction Cartridges
Lumipulse® G E2-III

The CE marked Lumipulse® G E2-III immunoreaction cartridges are intended for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of estradiol (E2) in serum and plasma. E2 measurement can be used for evaluating ovarian function, monitoring of fertility therapy and determining the time of ovulation during in vitro fertilization. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

CYFRA Immunoreaction Cartridges
Lumipulse® G CYFRA (Cytokeratin Subunit 19 Fragment)

The CE marked Lumipulse® G CYFRA (Cytokeratin Subunit 19 Fragment) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of cytokeratin subunit 19 fragment (CYFRA) in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

CK-MB Immunoreaction Cartridges
Lumipulse® G CK-MB

The CE marked Lumipulse® G CK-MB immunoreaction cartridges are intended for in vitro diagnostic use with the LUMIPULSE G instruments for the quantitative measurement of the MB iso-enzyme of the creatine kinase (CK-MB) in human serum or plasma. This product is for professional use only. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme ImmunoAssay) technology with results that are available in up to 35 minutes.
More details

CEA-N Immunoreaction Cartridges
Lumipulse® G CEA-N (Carcinoembryonic Antigen)

The CE marked Lumipulse® G CEA-N (Carcinoembryonic Antigen) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of carcinoembryonic antigen (CEA) in serum or plasma. The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

CA19-9-N Immunoreaction Cartridges
Lumipulse® G CA19-9-N

The CE marked Lumipulse® G CA19-9-N immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of CA19-9-N in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

CA15-3 Immunoreaction Cartridges
Lumipulse® G CA15-3

The CE marked Lumipulse® G CA15-3 immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of CA15-3 in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

CA125-II Immunoreaction Cartridges
Lumipulse® G CA125-II

The CE marked Lumipulse® G CA125-II immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of CA125 in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

C-Peptide Immunoreaction Cartridges
Lumipulse® G C-Peptide

The CE marked Lumipulse® G C-Peptide immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of C-peptide in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

BNP Immunoreaction Cartridges
Lumipulse® G BNP

The CE marked Lumipulse® G BNP immunoreaction cartridges are intended for in vitro diagnostic use with the LUMIPULSE G instruments for the quantitative measurement of human B-type natriuretic peptide (BNP) in human plasma. BNP measurement is highly useful for the diagnosis of heart failure. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme ImmunoAssay) technology with results that are available in up to 35 minutes.
More details

AMH Immunoreaction Cartridges
Lumipulse® G AMH (anti-Müllerian hormone)

The CE marked Lumipulse® G AMH (anti-Müllerian hormone) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the fully automated quantitative measurement of AMH in specimens based a two-step immunoassay method on the LUMIPULSE G System. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

Aldosterone Immunoreaction Cartridges
Lumipulse® G Aldosterone

The CE marked Lumipulse® G Aldosterone immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of aldosterone in human serum, plasma, or urine. Aldosterone measurement is of help in the diagnosis and treatment of primary aldosteronism.
More details

AFP-N Immunoreaction Cartridges
Lumipulse® G AFP-N (Alpha-Fetoprotein)

The CE marked Lumipulse® G AFP-N (Alpha-Fetoprotein) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of alpha-fetoprotein (AFP) in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

25-OH Vitamin D Immunoreaction Cartridges
Lumipulse® G 25-OH Vitamin D

The CE marked Lumipulse® G 25-OH Vitamin D immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative determination of 25-hydroxyvitamin D (25-OH-D) in human serum or plasma to be used in the assessment of Vitamin D sufficiency.
More details

BNP Control
Lumipulse® BNP Control

The CE marked Lumipulse® BNP Control are intended for use as an assayed quality control to monitor the precision of laboratory testing procedures for the analysis of human B-type natriuretic peptide (BNP) on the LUMIPULSE G Systems.
More details

PCT Control
Lumipulse® B.R.A.H.M.S PCT Control

The CE marked Lumipulse® B.R.A.H.M.S PCT controls are intended for use as an assayed control material to monitor the precision of laboratory testing procedures for the analysis of procalcitonin on the LUMIPULSE G Systems.
More details

IL-6 LPG Immunoreaction Cartridges
IL-6 (Interleukin) LPG

The IL-6 (Interleukin) LPG immunoreaction cartridges are intended for research use with the LUMIPULSE G system for the quantitative measurement of IL-6 in serum or plasma.
More details

AMH Control
AMH Control

The CE marked AMH Control is intended for use as an assayed control material to monitor the precision of laboratory testing procedures for the analysis of Anti Müllerian Hormone (AMH) with the LUMIPULSE G System.
More details

Immunoassay Analyzer
RoboBlot™ Non-Heated

The CE marked RoboBlot™ Non-Heated is a closed system that offers fully automated processing of INNO-LIA® tests from sample pipetting to strip reading and LiRAS® interpretation, transforming tedious manual work into a completely automated throughput of high testing volumes, ensuring ease of use, chain of custody (Pos ID), and consistent performance.
More details

Software
LiRAS® for LiPA® HPV (CE Marked)

The LiRAS® for LiPA® HPV (CE Marked) software assists in the interpretation of the HPV genotyping results after scanning of the LiPA strips for HPV genotyping (attached to a LiPA-Scan reading template), or manual entry of the probe reactivities.
More details

Software
LiRAS® for LiPA® HPV (RUO)

The LiRAS® for LiPA® HPV (RUO) software assists in the interpretation of the HPV genotyping results after scanning of the LiPA strips for HPV genotyping (attached to a LiPA-Scan reading template), or manual entry of the probe reactivities.
More details

Software
LiRAS® for LiPA® HLA

The CE-Marked LiRAS® for LiPA® HLA software assists in the interpretation of the HLA typing results after scanning of the LiPA strips for HLA (attached to a LiPA-Scan reading template), or manual entry of the probe reactivities.
More details

Software
LiRAS® for LiPA® HBV (CE-Marked)

The CE-Marked LiRAS® for LiPA® HBV software assists in the objective reading and interpretation of the INNO-LIPA® HBV portfolio.
More details

Software
LIRAS® for LIPA® HBV (RUO)

The LIRAS® for LIPA® HBV (RUO) software assists in the objective reading and interpretation of the INNO-LIPA® HBV portfolio.
More details

Software
LiRAS® for LiPA® Cystic Fibrosis

The CE Marked LiRAS® for LiPA® Cystic Fibrosis software assists in the objective reading and interpretation of INNO-LiPA® strips for detection of CFTR mutations and wild-type.
More details

Software
LiRAS® for LIA® ANA (CE Marked)

The CE Marked LiRAS® for LIA® ANA software assists in the interpretation of LIA ANA test results after scanning of the INNO-LIA® strips (attached to a LIA-Scan™ reading template).
More details

Software
LiRAS® for LIA® ANA (RUO)

The LiRAS® for LIA® ANA (RUO) software assists in the interpretation of LIA ANA test results scanning of the INNO-LIA® strips (attached to a LIA-Scan™ reading template).
More details

Software
LiRAS® for Infectious Diseases

The CE marked LiRAS® for Infectious Diseases software assists in the interpretation of the results after scanning of the INNO-LIA strips of the infectious diseases kits (attached to a LIA-Scan™ reading template).
More details

β-AMYLOID (1-42) Immunoassay - CE Marked
INNOTEST® β-AMYLOID (1-42) - CE Marked

The CE marked INNOTEST® β-AMYLOID (1-42) is a solid-phase enzyme immunoassay for the quantitative determination of β-amyloid (1-42) in human cerebrospinal fluid (CSF). The combined use of CSF-Tau and CSF-β-amyloid (1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression.
More details

β-AMYLOID (1-42) Immunoassay - RUO
INNOTEST® β-AMYLOID (1-42) - RUO

The INNOTEST® β-AMYLOID (1-42) – RUO is a solid-phase enzyme immunoassay for the quantitative determination of β-amyloid(1-42) in human cerebrospinal fluid (CSF). The combined use of CSF-Tau and CSF-β-amyloid (1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression.
More details

β-AMYLOID (1-40) Immunoassay - RUO
INNOTEST® β-AMYLOID (1-40) - RUO

The INNOTEST® β-AMYLOID (1-40) – RUO is a solid-phase enzyme immunoassay for the quantitative determination of β-amyloid (1-40) in human cerebrospinal fluid (CSF).
More details

β-AMYLOID(1-40) Immunoassay CE Marked
INNOTEST® β-AMYLOID(1-40) CE Marked

The CE marked INNOTEST® β-AMYLOID (1-40) is a solid-phase enzyme immunoassay for the quantitative determination of β-amyloid (1-40) in human cerebrospinal fluid (CSF)1,2 in the clinical setting of dementia diagnosis. Values for the 40- and 42-AA-long β-amyloid peptides can be expressed as a β-amyloid ratio, which is of particular use in patients in which an indeterminate CSF biomarker profile (based on 42-AA-long β-amyloid, TAU and Phospho-TAU) is observed.
More details

PHOSPHO-TAU (181P) Assay CE Marked
INNOTEST® PHOSPHO-TAU (181P) - CE Marked

The CE marked INNOTEST® PHOSPHO-TAU (181P) is a solid-phase enzyme immunoassay for the quantitative determination of phosphorylated Tau (Phospho-Tau (181P)) in human cerebrospinal fluid (CSF). The combined use of CSF-Tau and CSF-β-amyloid (1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression. The discrimination of AD from non-AD types of dementia such as dementia with Lewy Bodies may be further improved using the quantification of CSF-phospho-Tau (181).
More details

PHOSPHO-TAU (181P) Assay
INNOTEST® PHOSPHO-TAU (181P) (RUO)

The INNOTEST® PHOSPHO-TAU (181P) (RUO) is a solid-phase enzyme immunoassay for the quantitative determination of phosphorylated Tau (Phospho-Tau (181P)) in human cerebrospinal fluid (CSF). The combined use of CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression. The discrimination of AD from non-AD types of dementia such as dementia with Lewy Bodies may be further improved using the quantification of CSF-phospho-Tau(181).
More details

hTAU Ag Assay (CE Marked)
INNOTEST® hTAU Ag (CE Marked)

The CE marked INNOTEST® hTAU Ag is a solid-phase enzyme immunoassay for the quantitative determination of Tau protein in human cerebrospinal fluid (CSF). This assay measures the biomarker called total Tau, including the six isoforms (352 to 441 amino acids) from the brain. The combined use of CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression (1-6).
More details

hTAU Ag Assay (RUO)
INNOTEST® hTAU Ag

The CE marked INNOTEST® hTAU Ag (RUO) is a solid-phase enzyme immunoassay for the quantitative determination of Tau protein in human cerebrospinal fluid (CSF). This assay measures the biomarker called total Tau, including the six isoforms (352 to 441 amino acids) from the brain. The combined use of CSF-Tau and CSF-β-amyloid (1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression (1-6).
More details

hPLAP Assay
INNOTEST® hPLAP

The CE marked INNOTEST® hPLAP is an enzyme immunoassay based on a unique monoclonal antibody for the quantitative determination of human placental alkaline phosphatase (hPLAP) in serum and heparinized plasma. hPLAP (human placental alkaline phosphatase) is a marker for diagnosis and monitoring of seminomas.
More details

HIV p24 Antigen Test
INNOTEST® HIV Antigen mAb

The CE marked INNOTEST® HIV Antigen mAb is an enzyme immunoassay for the qualitative detection of HIV p24 antigen in human serum, plasma, and cell culture supernatant. The kit contains reagents for confirmation of HIV p24 antigens in repeatedly reactive samples.
More details

HCV Immunoassay
INNOTEST® HCV Ab IV

The CE marked INNOTEST® HCV Ab IV is an enzyme immunoassay for the detection of antibodies to human hepatitis C virus (HCV) in human serum or plasma and in which the wells of polystyrene microplate strips are coated with a mixture of HCV antigens. This 4th generation assay has increased sensitivity due to the use of antigens with improved reactivity, derived from the most prevalent HCV genotypes. Antibodies reactive with the core (2 different epitope clusters), NS3, NS4A, NS4B, and NS5A regions of HCV genotypes 1a and 1b, as well as the NS3 and NS4 regions of HCV genotypes 2 and 3a can be detected. The assay is easy to use with a sample addition monitoring system, color-coded reagents, and sample volume of 20 µL.
More details

MYCOBACTERIA Assay
INNO-LiPA® MYCOBACTERIA v2

The CE marked INNO-LiPA® MYCOBACTERIA v2 is a line probe assay for the simultaneous detection and identification of the genus Mycobacterium and 16 different mycobacterial species on one strip. The test is based on the nucleotide differences in the 16S-23S rRNA spacer region and can be performed starting from either liquid or solid culture.
More details

HLA-DRB1 Assay
INNO-LiPA® HLA-DRB1 Plus

The CE marked INNO-LiPA® HLA-DRB1 Plus is a line probe assay for the molecular typing of human leukocyte antigen (HLA) DRB1 alleles at allele group level (DRB1*01–DRB1*16). It detects all known alleles of HLA-DRB1 (except for DRB1*1130) with one amplification and one strip.
More details

HLA-DRB Assay
INNO-LiPA® HLA-DRB Decoder

The CE marked INNO-LiPA® HLA-DRB decoder is a line probe assay for the molecular typing of human leukocyte antigen (HLA) DRB alleles at allelic level (DRB1, DRB3, DRB4, DRB5). It detects all known alleles of HLA-DRB1 in combination with their associated alleles (DRB3, DRB4, or DRB5), by the use of up to four amplification reactions and up to two probe strips with each amplification reaction.
More details

HLA-DQB1 Assay
INNO-LiPA® HLA-DQB1 Update

The CE marked INNO-LiPA® HLA-DQB1 Update is a line probe assay for the molecular typing of human leukocyte antigen (HLA) DQB1 alleles at allelic level (DQB1*02–DQB1*06).
More details

HLA-DQA1 Assay
INNO-LiPA® HLA-DQA1

The CE marked INNO-LiPA® HLA-DQA1 is a line probe assay for the molecular typing of human leukocyte antigen (HLA) DQA1 alleles at allelic level (DQA1*01–DQA1*06).
More details

HLA-C Assay
INNO-LiPA® HLA-C

The CE marked INNO-LiPA® HLA-C is a line probe assay for the molecular typing of human leukocyte antigen (HLA) C alleles at allele group level (Cw*01 – Cw*18).
More details

HLA-B Assay
INNO-LiPA® HLA-B Update Plus

The CE marked INNO-LiPA® HLA-B Update Plus is a line probe assay for the molecular typing of human leukocyte antigen (HLA) B alleles at allele group level (B*07 – B*83). Bw4/Bw6 ambiguities can be resolved by an additional Bw4-specific amplification and hybridization on one strip.
More details

HLA-A Assay
INNO-LiPA® HLA-A Update

The CE marked INNO-LiPA® HLA-A Update is a line probe assay for the molecular typing of human leukocyte antigen (HLA) A alleles at allele group level (A*01–A*80).
More details

HBV PreCore Assay
INNO-LiPA® HBV PreCore (RUO)

The INNO-LiPA® HBV PreCore (RUO) is a line probe assay for the simultaneous detection of wild-type motif and mutations in the basal core promoter and precore regions of the hepatitis B virus genome. The assay is designed to identify nucleotide polymorphisms at nt1762 and nt1764 in the basal core promoter region and at codon 28 in the precore region.
More details

HBV Multi-DR Assay (CE Marked)
INNO-LIPA® HBV Multi-DR (CE Marked)

The CE marked INNO-LIPA® HBV Multi-DR is a line probe assay for simultaneous detection of hepatitis B virus wild-type motif, lamivudine, telbivudine, emtricitabine, adefovir, and entecavir resistance-associated mutations.
More details

HBV Multi-DR Assay
INNO-LiPA® HBV Genotyping (RUO)

The INNO-LIPA® HBV Multi-DR (RUO) is a line probe assay for simultaneous detection of hepatitis B virus wild-type motif, lamivudine, telbivudine, emtricitabine, adefovir, and entecavir resistance-associated mutations.
More details

HBV Genotyping Assay
INNO-LiPA® HBV Genotyping

The CE marked INNO-LiPA® HBV Genotyping is a line probe assay designed to identify hepatitis B virus genotypes A to H by the detection of type-specific sequences in the HBV polymerase gene domain B to C.
More details

CFTR iage Line Probe Assay
INNO-LiPA® CFTR iage

The CE marked INNO-LiPA® CFTR iage is a line probe assay, intended for the simultaneous in vitro detection and identification of 88 human Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene mutations and their wild type sequence in human whole blood, dried blood spots or buccal brushes. This qualitative genotyping test provides information for carrier testing in adults of reproductive age, can be used as an aid in newborn screening as well as in confirmatory diagnostic testing. The assay uses amplification reagents intended for the nucleic acid multiplex amplification of 40 regions of the CFTR gene (regions for some mutations are combined) in only one reaction. The INNO-LiPA CFTR iage approach provides a multiparameter screening test for CFTR gene mutations and discriminates between healthy normal individuals, healthy carriers, and affected patients.
More details

CFTR 19 Line Probe Assay
INNO-LiPA® CFTR 19

The CE marked INNO-LiPA® CFTR 19 is a multiparameter line probe assay, based on the reverse hybridization principle, for the simultaneous detection and identification of 35 cystic fibrosis-related mutations and their wild-type sequences in human whole blood, dried blood spots, and buccal brush samples. In addition, probes for the identification of the Tn polymorphism within intron 8 are included.
More details

CFTR 17+Tn Line Probe Assay
INNO-LiPA® CFTR 17+Tn Update

The CE marked INNO-LiPA® CFTR 17+Tn Update is a multiparameter line probe assay, based on the reverse hybridization principle, for the simultaneous detection and identification of 36 Cystic Fibrosis-related mutations and their wild-type sequences in human whole blood, dried blood spots, and buccal brush samples. In addition, probes for the identification of the Tn polymorphism within intron 8 are included.
More details

CFTR Italian Regional Assay
INNO-LiPA® CFTR Italian Regional

The CE marked INNO-LiPA® CFTR Italian Regional is a multiparameter line probe assay, based on the reverse hybridization principle, for the simultaneous detection and identification of 21 Italian Cystic Fibrosis-related mutations and their wild-type sequences in human whole blood, dried blood spots and buccal brush samples. This product is in addition to the INNO-LiPA CFTR 19 and INNO-LiPA CFTR 17+Tn Update kits that test for the most common mutations worldwide.
More details

CFTR Line Probe Assay
INNO-LIPA® CFTR Deletions+6

The CE marked INNO-LIPA® CFTR Deletions+6 is a multiparameter line probe assay, based on the reverse hybridization principle, for the simultaneous detection and identification of 8 large rearrangements and 6 mutations and their wild-type sequences in human whole blood, dried blood spots, and buccal brush samples. For the detection and identification of all ACMG mutations the INNO-LiPA CFTR 19 and INNO-LiPA CFTR 17+Tn Update kits are both required to be tested (testing for 35 mutations, one polymorphism and three Tn variants).
More details

Syphilis Immunoassay (CE marked)
INNO-LIA® Syphilis Score (CE marked)

The CE marked INNO-LIA® Syphilis Score is a line immunoassay to confirm the presence of antibodies against Treponema pallidum in human serum or plasma.
More details

Syphilis Immunoassay (RUO)
INNO-LIA® Syphilis Score (RUO)

The INNO-LIA® Syphilis Score is a line immunoassay for research use only to confirm the presence of antibodies against Treponema pallidum in human serum or plasma.
More details

HTLV-I/II Immunoassay
INNO-LIA® HTLV I/II Score

The CE marked INNO-LIA® HTLV I/II Score is a line immunoassay for the confirmation and discrimination of antibodies to Human T-cell Lymphotrophic Virus type I (HTLV-I) and type II (HTLV-II) in human serum and plasma. The assay uses well-defined antigens derived from HTLV I and HTLV II immunodominant proteins.
More details

HCV Immuonassay
INNO-LIA® HCV Score

The CE marked INNO-LIA® HCV Score is a line immunoassay for the detection of antibodies to human hepatitis C virus in human serum and plasma. It is intended for use as a supplementary test on human serum or plasma specimens found to be reactive in an anti-HCV screening procedure. The INNO-LIA HCV Score assay utilizes well-defined antigens derived from HCV immunodominant proteins from the core region, the E2 hypervariable region (HVR), the NS3 helicase region and the NS4A, NS4B and NS5A regions. The antigens used are either recombinant proteins or synthetic peptides, highly purified, and fixed on a nylon membrane.
More details

Immunoassay Test
INNO-LIA® ANA Update

The CE marked INNO-LIA® ANA Update is a line immunoassay for the detection and identification of autoantibodies against nuclear and cytoplasmic antigens in human serum, with the ability to identify 13 autoantigens in one run.
More details

Treponema Pallidum Reagent
ESPLINE® TP

The CE marked ESPLINE® TP reagent is based on the principle of immuno-chromatography for detection of antibodies to Treponema pallidum (TP) in serum or plasma samples. The test kit employs two recombinant antigens that are considered to be the main antigens of TP. These recombinant antigens are fixed to a membrane in the test part of the cassette. An enzyme-labeled antigen pad, a substrate pad, and a developing solution are also included in the cassette.
More details

SARS-CoV-2 Assay
ESPLINE® SARS-CoV-2

The CE marked ESPLINE® SARS-CoV-2 is a cassette-style immunochromatographic assay for in vitro diagnostic (IVD) use for the detection of SARS-CoV-2 antigen directly from nasopharyngeal swab fluid. It can detect SARS-CoV-2 within 30 minutes using a simple procedure without any special instruments and is intended for use as an aid in the diagnosis of SARS-CoV-2 infection.
More details

Reagent
ESPLINE® Influenza A&B-N

The CE marked ESPLINE® Influenza A&B-N is a cassette-style reagent for detection of influenza A & B virus antigens using a simple procedure without any special instrument. It uses immuno-chromatography technology based on the principle of enzyme immunoassay. Both the influenza A virus antigen and influenza B virus antigen from nasal swab fluid, pharyngeal swab fluid, and nasal aspirate fluid can be detected by a single test.
More details

Real-Time PCR Detection System
PowerGene 9600 Plus

The CE marked PowerGene 9600 Plus Real-Time PCR detection system features a specially-made Ferrotec Peltier, advanced fiber optic technology, a new global wide-range power supply, the unique patented block dissipation technology and bottom detection mode, that help it provide better heating/cooling rate, temperature accuracy, uniformity and stability. The design of 5 channel detection covers the whole fluorescence detection wavelength and the PowerGene 9600 Plus has a high speed of dual-color scanning. The newly-designed automatic hot-lid without manual operation ensures constant pressure for various tube heights.
More details

HPV Genotyping Assay
AmpFire® HPV Screening 16/18/HR

The CE marked AmpFire® HPV Screening 16/18/HR kit is intended for fast, simple, and accurate qualitative detection and identification of 15 High-Risk HPV types with simultaneous genotyping of HPV16 and 18 in one tube.
More details

HPV Genotyping Assay
AmpFire® HPV High Risk Genotyping

The CE marked AmpFire® HPV High Risk Genotyping kit is intended for fast, simple, and accurate qualitative detection and identification of 15 High-Risk HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, and 68.
More details

COVID-19 Test
iAMP COVID-19 Detection Kit

The CE marked iAMP COVID-19 Detection Kit is designed for the qualitative nucleic acid detection of SARS-CoV-2 (COVID-19) on naso- or oropharyngeal swabs without pre-treatment. Using isothermal amplification with real time fluorescence detection, the kit requires limited hands-on time and delivers fast sample-to-result within 75 to 90 minutes only.
More details

SARS-CoV-2 Antibody Test
Lumipulse G SARS-CoV-2 Ag

The CE marked Lumipulse G SARS-CoV-2 Ag is designed for in vitro diagnostic (IVD) use with the Lumipulse G system for the detection and quantitative measurement of SARS-CoV-2 antigen in human nasopharyngeal swab or saliva. The assay is meant to be used as a diagnostic tool for the confirmation of a SARS-CoV-2 infection and utilizes proven CLEIA (chemiluminescent enzyme immunoassay) technology with results available in up to 35 minutes.
More details

CTFR Genotyping Assay
INNO-LiPA CFTR Extra

The CE marked INNO-LiPA® CFTR Extra is a line probe assay, intended for the simultaneous in vitro detection and identification of 18 human Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene mutations and their wild type sequence in human whole blood, dried blood spots or buccal brushes. This qualitative genotyping test provides information for carrier testing in adults of reproductive age, can be used as an aid in newborn screening as well as in confirmatory diagnostic testing.
More details

HE4 Immunoreaction Cartridges
Lumipulse G HE4 (Human epididymis protein 4)

The CE marked Lumipulse G HE4 is a Chemiluminescent Enzyme Immunoassay (CLEIA) for in vitro diagnostics (IVD) use for the quantitative measurement of HE4 (Human epididymis protein 4) in human serum or plasma (sodium heparin, lithium heparin, or dipotassium EDTA) on the LUMIPULSE G system. The assay is the first new biomarker in 30 years for ovarian cancer management and utilizes proven CLEIA technology to deliver results in up to 35 minutes.
More details

HPV Genotyping Assay
INNO-LiPA HPV Genotyping Extra II (20T)

The CE marked INNO-LiPA® HPV Genotyping Extra II is a line probe assay, based on the reverse hybridization principle, designed for the identification of 32 different genotypes of the human papillomavirus (HPV). It comes with easy and ready-to-use master mix along with Taq DNA polymerase for minimum manipulation steps and hands-on time.
More details

Immunoassay Test
INNO-LIA HIV I/II Score (20T)

The CE marked INNO-LIA® HIV I/II Score immunoblot assay is intended for the confirmation and discrimination of antibodies to HIV-1, HIV-1 group O and HIV-2 in human serum and plasma. The INNO-LIA HIV I/II Score test contains recombinant proteins and synthetic peptides from HIV-1 and HIV-2 as well as a synthetic peptide from HIV-1 group O. These carefully selected antigens are coated at optimal concentrations as discrete lines on a nylon strip with plastic backing.
More details

PCT Assay
Lumipulse G B•R•A•H•M•S PCT Assay

The CE marked Lumipulse G B•R•A•H•M•S PCT is a Chemiluminescent Enzyme Immunoassay (CLEIA) for the quantitative determination of PCT (procalcitonin) in human serum and plasma (sodium heparin, lithium heparin, sodium citrate or dipotassium EDTA) on the LUMIPULSE G System. It offers excellent precision with a CV of ≤4.7% with results available in up to 35 minutes, making it an ideal aid for decision-making in patients with suspected or confirmed lower respiratory tract infection.
More details

Immunoassay Analyzer
TENDIGO

The TENDIGO immunoassay analyzer turns daily manual work into automation for low throughput testing volumes with validated INNO-LIA and INNO-LIPA assay protocols on board and open protocol programming. Other features include easy operation, minimum hands-on time, walkaway principle, and dry heating on board for fast and accurate processing.
More details

HTLV-I/II Immunoreaction Cartridges
Lumipulse G HTLV-I/II

The CE marked Lumipulse G HTLV-I/II immunoreaction cartridges is meant for in vitro diagnostic use with the LUMIPULSE G System for qualitative detection of antibody to HTLV-I and HTLV-II in human serum or plasma for screening of HTLV-I/II viral infection. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme ImmunoAssay) technology with results that are available in up to 35 minutes.
More details

CLEIA Analyzer
LUMIPULSE G600 II

The CE marked LUMIPULSE G600II, the latest member of the LUMIPULSE G series chemiluminescent enzyme immunoassay (CLEIA) analyzers from Fujirebio, uses a unique mono test cartridge concept and features a constant throughput of 60 tests per hour. The compact and robust benchtop analyzer provides a perfect fit in hospitals and clinical laboratories aiming for personalized workflow solutions without compromising testing quality, offering outstanding flexibility and easy handling.
More details

CLEIA Analyzer
LUMIPULSE G1200

The CE marked LUMIPULSE G1200 is a robust mid-sized fully automated immunoassay instrument that uses a unique mono test cartridge concept and performs a true throughput of 120 tests per hour. A member of Fujirebio’s already widely successful LUMIPULSE G series, it provides outstanding flexibility and easy handling in hospitals and clinical laboratories.
More details
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions